13th May 2025 07:00
Click on, or paste the following link into your web browser, to view the associated PDF document.
http://www.rns-pdf.londonstockexchange.com/rns/4189I_1-2025-5-13.pdfCondensed Consolidated Interim Statement of Financial Position as at March 31, 2025
Notes | Mar. 31, 2025 |
| Dec. 31, 2024 | |
|
|
| ||
Assets |
|
|
| |
Cash and balances at the central bank | 9 | 68,810,514 |
| 136,531,020 |
Due from banks | 10 | 314,305,928 |
| 270,829,834 |
Loans and advances to banks, net | 12 | 16,109,873 |
| 9,555,410 |
Loans and advances to customers, net | 13 | 364,274,475 |
| 343,542,674 |
Derivative financial instruments | 930,893 |
| 819,711 | |
Financial investments |
|
|
| |
- Financial Assets at Fair Value through OCI | 14 | 261,161,290 |
| 234,512,167 |
- Financial Assets at Amortized cost | 14 | 189,243,425 |
| 168,118,219 |
Investments in associates | 15 | 35,384 |
| 98,193 |
Other assets | 16 | 40,510,451 |
| 44,282,773 |
Deferred tax assets | 2,804,720 |
| 2,685,331 | |
Property and equipment | 17 | 4,698,499 | 3,997,929 | |
Total assets |
| 1,262,885,452 |
| 1,214,973,261 |
Liabilities and equity |
|
|
| |
Liabilities |
|
|
| |
Due to banks | 18 | 4,321,002 |
| 2,034,885 |
Due to customers | 19 | 1,000,617,577 |
| 972,595,958 |
Non-current liabilities held for sale | 30.2 | 1,397 |
| 1,397 |
Derivative financial instruments | 78,314 |
| 100,571 | |
Current income tax liabilities | 5,565,862 |
| 18,327,968 | |
Other liabilities | 20 | 46,045,132 |
| 21,441,169 |
Issued debt instruments | 21 | 5,044,951 |
| 5,067,781 |
Other loans | 23,948,624 |
| 23,962,389 | |
Other provisions | 22 | 19,045,051 | 18,621,822 | |
Total liabilities |
| 1,104,667,910 | 1,062,153,940 | |
Equity |
|
|
| |
Issued and paid capital | 30,431,580 |
| 30,431,580 | |
Reserves | 88,394,260 |
| 63,544,579 | |
Reserve for employee stock ownership plan (ESOP) | 2,184,420 |
| 1,868,235 | |
Retained earnings* |
| 36,940,838 | 56,791,883 | |
Total equity and net profit for the period / year |
| 157,951,098 | 152,636,277 | |
Non-Controlling Interest |
| 266,444 | 183,044 | |
Total NCI, equity and net profit for the period / year | 158,217,542 | 152,819,321 | ||
Total liabilities and equity | 1,262,885,452 | 1,214,973,261 | ||
|
| |||
The accompanying notes are an integral part of these financial statements. |
| |||
(Review report attached) |
| |||
*Including net profit for the period |
|
Islam Zekry | Hisham Ezz Al-Arab | |||
Group CFO & Executive Board Member | CEO & Executive Board Member | |||
| ||||
Condensed Consolidated Interim Income Statement for the period ended March 31, 2025
Notes |
| Mar. 31, 2025 |
| Mar. 31, 2024 | ||
|
|
| ||||
Interest and similar income | 52,535,156 |
| 36,652,802 | |||
Interest and similar expense |
| (27,139,272) | (17,852,691) | |||
Net interest income |
|
| 25,395,884 | 18,800,111 | ||
|
|
| ||||
Fee and commission income | 3,522,513 |
| 2,685,963 | |||
Fee and commission expense |
| (1,587,691) | (1,118,912) | |||
Net fee and commission income |
|
| 1,934,822 | 1,567,051 | ||
|
|
| ||||
Dividend income | 12,751 |
| 610 | |||
Net trading income | 6 | 644,549 |
| 16,202,148 | ||
Profits (Losses) on financial investments | 14.1 | 472,532 |
| 224,271 | ||
Administrative expenses | (3,932,425) |
| (2,928,640) | |||
Other operating income (expenses) | 7 | (1,742,230) |
| (14,975,056) | ||
Impairment release (charges) for credit losses |
| (84,032) |
| (1,421,114) | ||
Bank's share in the profits / losses of associates |
| (297) | 4,931 | |||
Profit before income tax |
| 22,701,554 | 17,474,312 | |||
|
|
| ||||
Income tax expense | 27 | (6,479,828) |
| (5,926,187) | ||
Deferred tax assets (Liabilities) | 27 |
| 411,443 | 376,765 | ||
Net profit for the period |
|
| 16,633,169 | 11,924,890 | ||
|
|
|
| |||
Non-Controlling Interest |
|
| 1,394 | 456 | ||
Bank's shareholders |
|
| 16,631,775 | 11,924,434 | ||
|
|
|
| |||
Earnings per share | 8 |
|
|
| ||
Basic |
| 4.83 |
| 3.47 | ||
Diluted |
| 4.79 |
| 3.45 | ||
Islam Zekry |
| Hisham Ezz Al-Arab | ||||
Group CFO & Executive Board Member |
| CEO & Executive Board Member |
Condensed Consolidated Interim statement of Comprehensive Income for the period ended March 31, 2025 | ||||
| Last 9 Months | Last 9 Months | ||
| Mar. 31, 2025 |
| Mar. 31, 2024 | |
|
|
|
| |
Net profit for the period |
| 16,633,169 | 11,924,890 | |
|
|
| ||
Net change on financial assets at fair value through comprehensive income after tax |
| 2,491,322 |
| 1,915,786 |
Cumulative foreign currencies translation differences |
| (169,708) |
| 831,452 |
Effect of ECL on fair value of debt instruments measured at fair value through comprehensive income |
| 841,687 | 744,813 | |
Total comprehensive income for the period |
| 19,796,470 | 15,416,941 | |
| ||||
As follows: |
| |||
Bank's shareholders |
| 19,713,070 |
| 15,416,485 |
Non-Controlling Interest |
| 83,400 | 456 | |
Total comprehensive income for the period |
| 19,796,470 | 15,416,941 |
Condensed Consolidated Interim Cash flows for the period ended March 31, 2025 | ||||
| ||||
Notes | Mar. 31, 2025 |
| Mar. 31, 2024 | |
|
|
| ||
Cash flow from operating activities |
|
| ||
Profit before income tax |
| 22,701,554 |
| 17,474,312 |
Adjustments to reconcile profits to net cash provided by operating activities |
|
|
| |
Fixed assets depreciation | 17 | 773,002 |
| 261,427 |
Impairment release/charge for credit losses (Loans and advances to customers and banks) | (1,080,606) |
| 1,712,500 | |
Other provisions release/charge | 22 | 320,589 |
| 41,587 |
Impairment release/charge for credit losses (due from banks) | 141,071 |
| (646) | |
Impairment release/charge for credit losses (financial investments) | 1,023,567 |
| (290,740) | |
Impairment release/charge for other assets | - |
| (4,782) | |
Exchange revaluation differences for financial assets at fair value through OCI and AC | 212,785 |
| (17,328,576) | |
Revaluation differences impairment charge for Financial Assets at Fair value through OCI | (13,267) |
| 1,130,412 | |
Revaluation differences impairment charge for Financial Assets at Amortized cost | 1,240 |
| 95,225 | |
Revaluation differences impairment charge for due from banks | (18) |
| 1,393 | |
Net utilized / recovered of other provisions | 22 | (520) |
| (4,517) |
Exchange revaluation differences of other provisions | 22 | 103,160 |
| 3,574,589 |
Profits/losses from selling property and equipment | 7 | (6,006) |
| - |
Profits/losses from selling financial investments at fair value through OCI | 14.1 | (195,124) |
| (224,271) |
Profits/losses from selling investments in associates | (277,408) |
| - | |
Share based payments | 316,185 |
| 300,000 | |
Bank's share in the profits / losses of associates |
| 297 | (4,931) | |
Operating profits before changes in operating assets and liabilities |
| 24,020,501 | 6,732,982 | |
|
|
| ||
Net decrease / increase in assets and liabilities |
|
|
| |
Due from banks | 123,055,498 |
| 41,887,372 | |
Financial assets at fair value through P&L | - |
| (974,297) | |
Derivative financial instruments | (142,036) |
| 157,890 | |
Loans and advances to banks and customers | (26,205,658) |
| (37,541,091) | |
Other assets | 6,009,359 |
| (5,893,831) | |
Non-current assets held for sale | - |
| (244) | |
Due to banks | 18 | 2,286,117 |
| (6,928,939) |
Due to customers | 19 | 28,021,619 |
| 118,843,058 |
Current income tax obligations paid | (913,966) |
| (480,418) | |
Non-current liabilities held for sale | - |
| 1,297 | |
Other liabilities |
| 5,721,712 | 1,820,664 | |
Net cash generated from (used in) operating activities |
| 161,853,146 |
| 117,624,443 |
|
|
| ||
Cash flow from investing activities |
|
|
| |
Proceeds from sale of investments in associates | 226,698 |
| 4,782 | |
Payments for purchases of property, equipment and branches construction | (3,597,387) |
| (437,370) | |
Proceeds from selling property and equipment | 6,006 |
| - | |
Proceeds from redemption of financial assets at amortized cost | 2,579,713 |
| 285,507 | |
Payments for purchases of financial assets at amortized cost | (23,883,457) |
| (53,615,996) | |
Payments for purchases of financial assets at fair value through OCI | (29,279,247) |
| (26,592,698) | |
Proceeds from selling financial assets at fair value through OCI | 6,310,466 |
| 26,222,450 | |
Net cash generated from (used in) investing activities |
| (47,637,208) | (54,133,325) | |
| ||||
Condensed Consolidated Interim Cash flows for the period ended March 31, 2025 (Cont.) | ||||
| ||||
Mar. 31, 2025 |
| Mar. 31, 2024 | ||
|
|
| ||
Cash flow from financing activities |
|
|
| |
Other loans | (13,765) |
| 6,700,881 | |
Dividends paid | (14,160,152) |
| (5,078,792) | |
Issued debt instruments | (22,830) |
| 1,626,167 | |
Net cash generated from (used in) financing activities |
| (14,196,747) |
| 3,248,256 |
|
|
| ||
Net (decrease) increase in cash and cash equivalent during the period | 100,019,191 |
| 66,739,374 | |
Beginning balance of cash and cash equivalent | 226,610,721 | 234,317,913 | ||
Cash and cash equivalent at the end of the period |
| 326,629,912 |
| 301,057,287 |
|
|
| ||
Cash and cash equivalent comprise: |
|
|
| |
Cash and balances at the central bank | 9 | 68,810,514 |
| 36,731,091 |
Due from banks | 314,450,806 |
| 292,723,938 | |
Treasury bills and other governmental notes | 11 | 116,419,815 |
| 119,754,167 |
Obligatory reserve balance with central bank | (43,885,546) |
| (19,531,282) | |
Due from banks with maturity more than three months | (14,867,792) |
| (8,740,302) | |
Treasury bills and other governmental notes with maturity more than three months |
| (114,297,885) | (119,880,325) | |
Total cash and cash equivalent |
| 326,629,912 |
| 301,057,287 |
Condensed Consolidated Interim statement of changes in shareholders' equity |
| |||||||||||||
Mar. 31, 2024 | Issued and paid capital | Legal reserve | General reserve | General risk reserve | Reserve for transactions under common control | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Cumulative foreign currencies translation differences | Total Shareholders' Equity | Non-Controlling Interest | Total |
| ||||||||||||||
Beginning balance | 30,195,010 | 4,770,354 | 39,840,707 | 1,550,906 | (670,972) | 21,155 | (16,868,691) | 15,230 | 29,993,331 | 1,486,010 | 148,353 | 90,481,393 | 160,073 | 90,641,466 |
Transferred to reserves | - | 1,438,320 | 21,958,960 | - | - | 1,663 | - | - | (23,398,943) | - | - | - | - | - |
Net profit for the period | - | - | - | - | - | - | - | - | 11,924,434 | - | - | 11,924,434 | 456 | 11,924,890 |
Dividends paid | - | - | - | - | - | - | - | - | (5,366,429) | - | - | (5,366,429) | - | (5,366,429) |
Net change on financial assets at fair value through OCI after tax | - | - | - | - | - | - | 1,915,786 | - | - | - | - | 1,915,786 | - | 1,915,786 |
Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | 21,718 | (21,718) | - | - | - | - | - |
Effect of ECL in fair value of debt instruments measured at fair value through OCI | - | - | - | - | - | - | 744,813 | - | - | - | - | 744,813 | - | 744,813 |
Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | 300,000 | - | 300,000 | - | 300,000 |
Cumulative foreign currencies translation differences | - | - | - | - | - | - | - | - | - | - | 831,452 | 831,452 | (321) | 831,131 |
Ending balance | 30,195,010 | 6,208,674 | 61,799,667 | 1,550,906 | (670,972) | 22,818 | (14,208,092) | 36,948 | 13,130,675 | 1,786,010 | 979,805 | 100,831,449 | 160,208 | 100,991,657 |
| ||||||||||||||
Mar. 31, 2025 | Issued and paid capital | Legal reserve | General reserve | General risk reserve | Reserve for transactions under common control | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Cumulative foreign currencies translation differences | Total Shareholders' Equity | Non-Controlling Interest | Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance | 30,431,580 | 6,208,674 | 62,422,792 | 1,550,906 | (670,972) | 22,818 | (7,145,283) | 17,924 | 56,791,883 | 1,868,235 | 1,137,720 | 152,636,277 | 183,044 | 152,819,321 |
Transferred to reserves | - | 2,771,284 | 18,971,298 | - | - | 2,246 | - | - | (21,744,828) | - | - | - | - | - |
Dividends paid | - | - | - | - | - | - | - | - | (14,714,434) | - | - | (14,714,434) | - | (14,714,434) |
Net profit for the period | - | - | - | - | - | - | - | - | 16,631,775 | - | - | 16,631,775 | 1,394 | 16,633,169 |
Transferred to general risk reserve | - | - | - | 26,186 | - | - | - | - | (26,186) | - | - | - | - | - |
Net change on financial assets at fair value through OCI after tax | - | - | - | - | - | - | 2,409,316 | - | - | - | - | 2,409,316 | 82,006 | 2,491,322 |
Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | (2,628) | 2,628 | - | - | - | - | - |
Effect of ECL in fair value of debt instruments measured at fair value through OCI | - | - | - | - | - | - | 841,687 | - | - | - | - | 841,687 | - | 841,687 |
Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | 316,185 | - | 316,185 | - | 316,185 |
Cumulative foreign currencies translation differences | - | - | - | - | - | - | - | - | - | - | (169,708) | (169,708) | - | (169,708) |
Ending balance | 30,431,580 | 8,979,958 | 81,394,090 | 1,577,092 | (670,972) | 25,064 | (3,894,280) | 15,296 | 36,940,838 | 2,184,420 | 968,012 | 157,951,098 | 266,444 | 158,217,542 |
Related Shares:
Com.int.bk.regs